Skip Nav

HIV/AIDS Clinical Trials

Recruiting Status Legend

Studies Seeking Participants

Recruiting
Not yet recruiting
Available for expanded access

Studies Not Seeking Participants

Active, not recruiting
Completed
Terminated
Suspended
Withdrawn
Enrolling by invitation
Temporarily not available for expanded access
No longer available for expanded access
Approved for marketing

Clinical Trial Search Results

48 studies were found about ( enfuvirtide OR Fuzeon )

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Condition: HIV1 Infection; HIV Infections

NCT ID: NCT00937729

Terminated

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00051831

Completed(En español)

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00001118

Completed(En español)

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00008528

Completed

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00021554

Completed

HIV Maintenance Therapy With T-20 During HAART Interruption

Condition: HIV Infection

NCT ID: NCT00013884

Completed

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00022763

Completed

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Completed

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Condition: Leukoencephalopathy, Progressive Multifocal; HIV Infections

NCT ID: NCT00120367

Completed

A Study of T-20 in HIV-Positive Adults

Condition: HIV Infections

NCT ID: NCT00002228

Completed

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00002239

Completed

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

Completed

Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00050856

Completed

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Condition: HIV Infections

NCT ID: NCT00031044

Completed(En español)

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

Condition: HIV Infections

NCT ID: NCT00461266

Terminated

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Condition: HIV Infections

NCT ID: NCT00102934

Active, not recruiting

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection

Condition: HIV Infections

NCT ID: NCT00232908

Completed

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Condition: HIV Infections

NCT ID: NCT00089492

Completed

Study of Enfuvirtide in HIV-Positive Subjects

Condition: HIV Infections; AIDS

NCT ID: NCT00086710

Completed

Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects

Condition: HIV Infections

NCT ID: NCT00529243

Completed

BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00337701

Completed

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

Condition: HIV Infections

NCT ID: NCT00233883

Completed

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Condition: HIV Infections

NCT ID: NCT00326963

Completed

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

Condition: HIV Infections

NCT ID: NCT00615134

Completed

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00488059

Terminated

Optimized Antiretroviral Therapy(ART)During Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in HIV-1 Individuals

Condition: HIV Positive Allogeneic Bone Marrow Transplant

NCT ID: NCT01836068

Not yet recruiting

Study of Valproic Acid to Treat HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00312546

Terminated(En español)

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

Completed

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

Condition: Human Immunodeficiency Virus Type 1

NCT ID: NCT00128830

Completed

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Condition: HIV Infections

NCT ID: NCT00187551

Completed

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Condition: HIV Infections

NCT ID: NCT00487188

Completed

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Completed

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

Condition: HIV Infections

NCT ID: NCT00344760

Completed

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Condition: HIV Infection

NCT ID: NCT00100984

Terminated

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

Condition: HIV Infections; Antiretroviral Treatment

NCT ID: NCT00216359

Active, not recruiting

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Condition: HIV

NCT ID: NCT00460746

Completed

Fuzeon Viral Decay Pilot Study

Condition: HIV-1

NCT ID: NCT00334022

Completed

Optimizing Treatment for Treatment-Experienced, HIV-infected People

Condition: HIV Infections

NCT ID: NCT00537394

Active, not recruiting(En español)

Metabolic Effects of Enfuvirtide in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00657761

Completed

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Condition: HIV Infection; Liver Failure; Evidence of Liver Transplantation

NCT ID: NCT01022476

Active, not recruiting

RAL-eve Study: Raltegravir Substitution Study

Condition: HIV Infections

NCT ID: NCT00523237

Completed

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Condition: HIV Infections

NCT ID: NCT00004735

Completed(En español)

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Condition: Human Immunodeficiency Virus

NCT ID: NCT00333736

Completed

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT01190124

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098748

Completed

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

Condition: HIV Infections

NCT ID: NCT00048217

Active, not recruiting

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Condition: Human Immunodeficiency Virus

NCT ID: NCT01814722

Recruiting

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

Completed